Syncope in Patients With an Implantable Cardioverter-Defibrillator: Incidence, Prediction and Implications for Driving Restrictions 11To discuss this article on-line, visit the ACC Home Page at www.acc.org/membersand click on the JACC Forum
| Autor: | Michael Block, Martin Borggrefe, Max Weber, J. Brunn, M. Castrucci, Dietmar Bänsch, Günter Breithardt, Frank Gietzen |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Fibrillation
Tachycardia medicine.medical_specialty Ejection fraction biology Defibrillation business.industry medicine.medical_treatment Syncope (genus) Poison control biology.organism_classification Implantable cardioverter-defibrillator Ventricular tachycardia medicine.disease Surgery Internal medicine medicine Cardiology medicine.symptom Cardiology and Cardiovascular Medicine business |
| Zdroj: | Journal of the American College of Cardiology. 31:608-615 |
| ISSN: | 0735-1097 |
| DOI: | 10.1016/s0735-1097(97)00543-3 |
| Popis: | Objectives. This retrospective study was undertaken to provide information on occurrence, risk prediction and prevention of syncope in patients with an implantable cardioverter-defibrillator (ICD).Background. ICDs effectively terminate ventricular tachycardia and fibrillation (VT/VF). Incapacitating symptoms, such as syncope, may still occur.Methods. We performed a retrospective analysis of data from 421 patients (clinical history, outpatient chart reviews and episode data) with mean (±SD) follow-up of 26 ± 18 months.Results. Of 421 patients, 229 (54.4%) had recurrent VT/VF, and 62 (14.7%) had syncope. The actuarial survival rate free of VT/VF was 58%, 45% and 37% and that for survival free of syncope was 90%, 85% and 81% at 12, 24 and 36 months after implantation, respectively. Once VT/VF had occurred, 76%, 68% and 62% of patients remained free of syncope during the following 12, 24 and 36 months, and 68%, 64% and 56% remained free of second syncope 12, 24 and 36 months after first syncope, respectively. In cases of syncope, the mean cycle length (CL) of VT was 251 ± 56 ms. A low baseline left ventricular ejection fraction (LVEF), induction of fast VT (CL 40%, fast VT had not been induced, and patients had no chronic AF; 96%, 92% and 92% of patients remained free of syncope after 12, 24 and 36 months, respectively. Once patients had a VT recurrence, syncope during the first VT and a high VT rate were the strongest risk predictors of future syncope.Conclusions. Identification of patients with an ICD with a low and high risk of syncope seems to be feasible and might help as a guide to driving restrictions in such patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|